UnitedHealth Group (UNH) seems to be caught in one controversy after another, with shares already down more than 40% year-to-date. Now, the largest U.S. health insurer is facing fresh pressure from lawmakers over billions of dollars in loans it issued to healthcare providers after last year’s cyberattack.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Senators Elizabeth Warren (D–Mass.) and Ron Wyden (D–Ore.) have asked the company to explain its repayment practices, following reports that some providers were pushed to return funds on short notice.
Fallout From UnitedHealth’s Cyberattack
In February 2024, UnitedHealth’s Change Healthcare unit — a major processor of medical claims — was hit by a cyberattack that crippled billing systems across the U.S. To ease the cash crunch, UnitedHealth set up a Temporary Funding Assistance Program, issuing more than $9 billion in interest-free loans to hospitals, doctors, and clinics.
Now, more than a year later, the repayment process has come under fire. Reports suggest UnitedHealth pressed many providers to repay loans within weeks or risk losing reimbursement for their claims. This has raised concerns in Washington, where lawmakers say providers were left in financial trouble by a crisis they did not cause.
Lawmakers Question Repayment Tactics
In a letter to UnitedHealth CEO Stephen Hemsley and Optum Financial CEO Dhivya Suryadevara, Senators Elizabeth Warren and Ron Wyden criticized what they called “hardball tactics” in the company’s loan collection efforts. They asked UnitedHealth to provide details on:
- The total number of loans issued
- Repayment terms
- Written agreements with providers
- Options available for providers unable to repay within 45 days
- Whether third-party debt collectors are involved
Lawmakers have set a deadline of September 12, 2025, for UnitedHealth to reply.
In response, a Change Healthcare spokesperson said the company has worked with “thousands of providers” to agree on repayment plans and noted that most have already met their obligations.
More Troubles Pile Up for UnitedHealth
The loan dispute adds to UnitedHealth’s growing list of regulatory problems. The Department of Justice (DOJ) is already investigating the company’s Medicare operations. Just recently, the DOJ has expanded its criminal investigation beyond Medicare Advantage billing to include other business practices. At the same time, the FTC is pressing forward with a lawsuit accusing UnitedHealth’s Optum Rx, along with other large PBMs (pharmacy benefit managers), of inflating insulin prices.
Earlier this month, Senators Warren and Wyden also opened a separate probe into whether UnitedHealth paid nursing homes bonuses for cutting down on hospital transfers.
What Is the Future of UNH Stock?
Turning to Wall Street, UNH stock has a Strong Buy consensus rating based on 17 Buys, two Holds, and one Sell assigned in the last three months. At $314.95, the average UnitedHealth stock price target implies a 4.19% upside potential.
